Your search returned 3 results.

Results
	1.	Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel H3-receptor antagonist/inverse agonist. [electronic resource] by Shah, Rashmi R Maison-Blanche, Pierre Robert, Philippe Denis, Emmanuel Duvauchelle, Thierry Producer: 20170109 In: European journal of clinical pharmacology vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study. [electronic resource] by Shah, Rashmi R Maison-Blanche, Pierre Duvauchelle, Thierry Robert, Philippe Denis, Emmanuel Producer: 20160906 In: European journal of clinical pharmacology vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. [electronic resource] by Ligneau, Xavier Landais, Laurent Perrin, David Piriou, Johanne Uguen, Marilyne Denis, Emmanuel Robert, Philippe Parmentier, Régis Anaclet, Christelle Lin, Jian-Sheng Burban, Aude Arrang, Jean-Michel Schwartz, Jean-Charles Producer: 20070531 In: Biochemical pharmacology vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)